Ticker AWH – Aspira Womens Health – sales, description, marketcap – Tickerday.com

AWH

Aspira Womens Health

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 305.23M; Volume: 226.07K; AvgVol 3m: 769.26K; Beta: 3.19;

Cost estimate:

P/E: –; EPS: -0.15; EPS growth quarter/prev quarter: 31.00%;

EPS growth this year: -8.50%; EPS growth past 5 years: 19.90%;

EPS ttm: -0.15;

P/S: 72.76; P/B: 44.71; P/Cashflow: 30.71; P/FCF: ;

Sales: 4.56M; Sales growth quarter/prev quarter: -36.40%; Sales growth past 5 years: 12.50%;

Profitability:

Gross Margin: 31.30%; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -109.60%; ROE – return on equity: -178.00%; LT Debt/Equity: 0.22; Total Debt/Equity: 0.30;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 1.60%; Insider Transactions:130.68%;

Institutional Ownership: 27.30%; Institutional Transactions: 27.09%;

Data update: 07/10/2020.